- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06941974
Partnering With Antenatal Navigators to Transform Health in Pregnancy (PATH)
The Partnering with Antenatal Navigators to Transform Health in Pregnancy (PATH) study aims to evaluate whether an antenatal patient navigation program improves maternal health, neonatal health, pregnant women's experiences, and health care utilization outcomes among low-income pregnant women and their neonates. Patient navigation is an individualized, barrier-focused, longitudinal, patient-centered intervention that offers support for a defined set of health services. In this randomized controlled trial, pregnant women who are randomized to receive antenatal patient navigation will be compared to pregnant women who are randomized to receive usual care. Navigators will support pregnant women from before 20 weeks of gestation through 2 weeks postpartum. The PATH intervention will be grounded in understanding and addressing factors that influence health and access to care in order to promote self-efficacy, enhance access, and sustain long-term engagement.
The main objectives of the study are to:
- Evaluate whether PATH, compared to usual care, improves maternal health outcomes. We hypothesize the PATH model of antenatal patient navigation for low-income women will reduce the incidence of a composite of adverse maternal outcomes, all of which are known to be increased among women with barriers to care.
- Evaluate whether PATH, compared to usual care, improves perinatal health outcomes. We hypothesize PATH will reduce the incidence of a composite of adverse perinatal outcomes. We will also investigate neonatal/pediatric health care utilization.
- Evaluate patient, clinician, navigator, and healthcare system experiences with PATH in preparation for widespread implementation and dissemination of the PATH obstetric navigation model. This aim will be accomplished through investigating patient-reported outcomes, completing qualitative and process mapping interviews with navigated participants, and completing qualitative and process mapping interviews with clinicians, navigators, and health administrators.
Study Overview
Status
Intervention / Treatment
Detailed Description
In the US, high rates of maternal morbidity are urgent public health concerns. Limited access to health care combined with other non-medical challenges generate greater risk of adverse maternal and neonatal outcomes for women with low income. High-quality antenatal care supports optimal health, yet typically fails to meet the needs of some populations, including those with lower incomes. Improving the health of pregnant women in a patient-centered manner requires innovative models of care delivery across the spectrum of maternal care. One strategy is patient navigation, a longitudinal, barrier- focused, patient-centered intervention that offers support for health services. Our prior work has included the study of patient navigation for low-income postpartum women, finding that assignment to a navigator improves the receipt of postpartum care and the successful transition to primary care. Although antenatal care is an ideal setting for patient navigation, the benefits of antenatal patient navigation for overall maternal and perinatal health have not been rigorously evaluated in randomized trials. There has been no study of antenatal patient navigation as a comprehensive, wraparound service to improve a wide range of pregnancy outcomes.
This randomized controlled trial aims to test the efficacy of an innovative antenatal care patient navigation model that extends and expands care for low-income pregnant women via the Partnering with Antenatal Navigators to Transform Health in Pregnancy (PATH) Trial. We will randomize nulliparous pregnant women with low income to receive antenatal patient navigation via the PATH program versus usual antenatal care. Participants randomized to receive PATH navigation will receive intensive, individualized patient navigation services throughout pregnancy. As a multilevel, multidomain, intervention, PATH navigation is grounded in understanding and addressing approaches to promote self-efficacy, enhance access, support communication, and sustain healthcare engagement. The PATH navigation program is a comprehensive antenatal patient navigator program which is guided by principles of barrier ascertainment and reduction, promotion of self-efficacy and health literacy skills, facilitation of communication, and enhancing antenatal care access. PATH navigators will incorporate best practices regarding non-medical needs assessment, motivational interviewing, health education, and capacity-building health behavior support.
The study will enroll and randomize 550 to 600 pregnant women, ages 16 and over, who have not had a previous live birth and who have publicly funded prenatal care or have low income. Participants assigned to navigation will be provided intensive, individualized, one-on-one navigation services from enrollment (at less than 20 weeks of gestation) through 2 weeks postpartum. All participants will undergo surveys, interviews, and medical record reviews at 5 study visits from enrollment (<20 weeks of gestation) through 9 months postpartum. Visits will occur at the following intervals: before 20 weeks (V1), 28-32 weeks of gestation (V2), at the time of hospitalization for delivery (V3), 6-12 weeks postpartum (V4), and 9 months postpartum (V5).
Aim 1 will evaluate whether PATH, compared to usual care, improves a composite of maternal adverse outcomes (including hypertensive disorders, preterm birth, postpartum hemorrhage, severe maternal morbidity, maternal mortality). Sub-Aim 1 aims to evaluate whether PATH, compared to usual care, improves effective maternal healthcare utilization (antenatal hospital use, Adequacy of Prenatal Care Utilization index, postpartum care/admission). Aim 2 will evaluate whether PATH, compared to usual care, improves a composite of perinatal adverse outcomes (including neonatal intensive care unit admission, low birthweight, small- and large-for-gestational age, perinatal death). Sub-Aim 2 aims to evaluate whether PATH, compared to usual care, improves effective neonatal/pediatric healthcare utilization (neonatal length-of-stay, neonatal hospital utilization, and pediatric care attendance). Exploratory Aims 1 and 2 will evaluate whether PATH's efficacy varies by different demographic factors (e.g. age), or chronic disease status.
Aim 3 will evaluate patient, clinician, navigator, and health system experiences with PATH in preparation for widespread implementation and dissemination of the PATH obstetric navigation model. This aim is guided by implementation science principles and will be accomplished via serial collection of patient-reported outcomes, individual interviews, and process mapping exercises. Specifically, Aim 3a will compare patient-reported outcomes, including perceived health status, quality of life, patient activation, stress level, and self-efficacy, for women who receive PATH navigation versus usual care. Aim 3b will use qualitative and process mapping methods among approximately 50 participants assigned to PATH to understand participants' engagement, feedback, pregnancy experience, antenatal care processes, and satisfaction with the level of social and medical care received with patient navigation. Aim 3c will similarly use qualitative and process mapping methods with approximately 20 clinicians, navigators, and health system administrators to understand the extent to which PATH facilitated clinical, administrative, and health system needs, as well as lessons for future program implementation, including the relative benefits of discrete elements of the PATH intervention.
The PATH Trial will fill a significant evidence gap by demonstrating whether antenatal patient navigation among low-income pregnant women, who are disproportionately at risk for adverse outcomes, is an effective strategy to improve perinatal health. The expected outcome of this project is to generate the empiric evidence needed to understand the effect of antenatal patient navigation and to plan for an optimized package of successful implementation strategies to prepare for broad dissemination.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lynn M Yee, MD, MPH
- Phone Number: 312-472-0119
- Email: lynn.yee@northwestern.edu
Study Contact Backup
- Name: Brittney R Williams, MPH
- Email: brittney.williams@northwestern.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Recruiting
- Northwestern Memorial Hospital
-
Contact:
- Brittney R Williams, MPH
- Phone Number: 312-503-3476
- Email: brittney.williams@northwestern.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Singleton gestation <20 weeks of gestation
- Nulliparous: no prior pregnancies ≥20 weeks excluding terminations
- Low income (public insurance or residence in a neighborhood in which >10% of household incomes are <125% of federal poverty line
- Ability to speak and read English or Spanish
- Established patient at one of practices associated with Northwestern Medical Group
- Age 16 years or older
Exclusion:
- Intent to transfer care to an outside institution
- Prior enrollment in PATH
- Concurrent enrollment in a study with competing aims/intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Non-navigation Group
No navigation will be provided; pregnant participants will receive usual care.
|
|
|
Experimental: Navigation Group
Pregnant participants who are randomized to receive PATH patient navigation will be assigned to a patient navigator.
The patient navigator will meet with the patient in early pregnancy for introductions, education, and assessing factors that influence health and access to care.
The patient navigator will offer support and resources (e.g., appointment coordination and scheduling, communication with clinical team, transportation, community referrals, support for mental health, support for other non-medical needs, etc.).
The navigator will provide support and continue linkage to resources through 2 weeks postpartum.
|
PATH navigation is an antenatal patient navigator program designed to reduce barriers to care, enhance access, improve self-efficacy and knowledge, and improve multiple perinatal health outcomes.
PATH navigation is a flexible, multi-pronged, patient-centered program with the capacity to evolve with patient needs and preferences.
Early in pregnancy, navigators will establish themselves as a non-medical resource and will introduce PATH as a program designed to help inform, support, and connect patients during pregnancy.
Navigators will review screen and address supportive and adverse non-medical needs, facilitate communication, perform logistical support, provide advocacy and bridge communication with clinical teams, and perform health education.
Navigation services will be tailored to individual medical, psychosocial, or logistical complexity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maternal adverse outcome composite (Aim 1 primary outcome)
Time Frame: Enrollment through delivery hospitalization, an average of 28 weeks
|
Frequency of maternal composite, which includes hypertensive disorders of pregnancy, preterm birth, postpartum hemorrhage, severe maternal morbidity, or maternal mortality.
Components of the primary outcome will also be examined as a score and individually as secondary outcomes (see below).
|
Enrollment through delivery hospitalization, an average of 28 weeks
|
|
Neonatal adverse outcome composite (Aim 2 primary outcome)
Time Frame: At birth/delivery
|
Frequency of the neonatal composite, which includes neonatal intensive care unit (NICU) admission, low birthweight, small-for-gestational-age (SGA), large-for-gestational-age (LGA) status, and/or perinatal death.
Components of the composite outcome will also be examined as a score and individually as secondary outcomes (see below).
|
At birth/delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hypertensive disorder of pregnancy (component of primary outcome)
Time Frame: Enrollment through delivery hospitalization, an average of 28 weeks
|
Frequency of de novo hypertensive disorder of pregnancy, including gestational hypertension, preeclampsia with or without severe features, superimposed preeclampsia on chronic hypertension, eclampsia, or HELLP syndrome
|
Enrollment through delivery hospitalization, an average of 28 weeks
|
|
Preterm birth (component of primary outcome)
Time Frame: Enrollment through delivery hospitalization, an average of 28 weeks
|
Frequency of birth less than 37 weeks of gestation
|
Enrollment through delivery hospitalization, an average of 28 weeks
|
|
Postpartum hemorrhage (component of primary outcome)
Time Frame: At birth/delivery
|
Frequency of estimated/quantitative blood loss >1000mL (during delivery hospitalization) or blood transfusion
|
At birth/delivery
|
|
Severe maternal morbidity (component of primary outcome)
Time Frame: Enrollment through delivery hospitalization, an average of 28 weeks
|
Frequency of CDC-defined indicators for severe maternal
|
Enrollment through delivery hospitalization, an average of 28 weeks
|
|
Maternal mortality (component of primary outcome)
Time Frame: Enrollment through delivery hospitalization, an average of 28 weeks
|
Frequency of maternal death (any reason) during pregnancy or the delivery hospitalization
|
Enrollment through delivery hospitalization, an average of 28 weeks
|
|
Neonatal intensive care unit admission (component of Aim 2 neonatal composite outcome)
Time Frame: At birth/delivery
|
Frequency of admission to the neonatal intensive care unit
|
At birth/delivery
|
|
Low birthweight (component of Aim 2 neonatal composite outcome)
Time Frame: Immediately post-birth
|
Frequency of birth weight <2500g
|
Immediately post-birth
|
|
Small-for-gestational-age (SGA) status (component of Aim 2 neonatal composite outcome)
Time Frame: Immediately post-birth
|
Frequency of birth weight <10%ile for gestational age and sex
|
Immediately post-birth
|
|
Large-for-gestational-age (LGA) status (component of Aim 2 neonatal composite outcome)
Time Frame: Immediately post-birth
|
Frequency of birth weight >90%ile for gestational age and sex
|
Immediately post-birth
|
|
Perinatal death (component of Aim 2 neonatal composite outcome)
Time Frame: 20 weeks of gestational through birth hospitalization
|
Frequency of intrauterine fetal demise (>20 weeks of gestation) or neonatal death (i.e., antenatal, intrapartum, or neonatal death)
|
20 weeks of gestational through birth hospitalization
|
|
Maternal health care utilization: Antenatal hospital utilization
Time Frame: Enrollment through delivery
|
Frequency of unanticipated obstetric triage or emergency department visit, or antepartum admission
|
Enrollment through delivery
|
|
Maternal health care utilization: Antenatal care adequacy
Time Frame: Enrollment through delivery
|
Adequacy of Prenatal Care Utilization Index score
|
Enrollment through delivery
|
|
Maternal health care utilization: Postpartum care
Time Frame: Between delivery and 12 weeks after delivery
|
Frequency of attendance at a routine postpartum care visit within 12 weeks after delivery
|
Between delivery and 12 weeks after delivery
|
|
Maternal health care utilization: Postpartum admission or emergency department use
Time Frame: Between delivery and 9 months postpartum
|
Frequency of hospital readmission or emergency department use within 9 months of delivery
|
Between delivery and 9 months postpartum
|
|
Neonatal health care utilization: Neonatal length of stay
Time Frame: During birth hospitalization
|
Neonatal length of birth hospitalization (days)
|
During birth hospitalization
|
|
Neonatal health care utilization: Neonatal hospital utilization
Time Frame: From birth hospital discharge through 9 months
|
Frequency of neonatal emergency department visit or hospital admission
|
From birth hospital discharge through 9 months
|
|
Neonatal health care utilization: Pediatric care attendance
Time Frame: From birth hospital discharge through 9 months
|
Frequency of attendance at indicated neonatal/pediatric outpatient care in the recommended time frame in the first 9 months of life
|
From birth hospital discharge through 9 months
|
|
Patient-reported outcome: Global health status
Time Frame: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
|
PROMIS Global Health score
|
During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
|
|
Patient-reported outcome: Health-related quality of life
Time Frame: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
|
Short Form Health Survey score
|
During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
|
|
Patient-reported outcome: Depressive symptoms
Time Frame: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
|
Patient Health Questionnaire-9 score
|
During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
|
|
Patient-reported outcome: Anxiety symptoms
Time Frame: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
|
General Anxiety Disorder-7 score
|
During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
|
|
Patient-reported outcome: Health-related self-efficacy
Time Frame: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
|
PROMIS Self-Efficacy-General score
|
During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
|
|
Patient-reported outcome: Difficulties in pregnancy
Time Frame: During pregnancy, delivery hospitalization, and 6-12 weeks postpartum
|
nuMoM2b Difficulties in Pregnancy Scale score
|
During pregnancy, delivery hospitalization, and 6-12 weeks postpartum
|
|
Patient-reported outcome: Stress
Time Frame: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
|
Perceived Stress Scale score
|
During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
|
|
Patient-reported outcome: Patient activation
Time Frame: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
|
Consumer Health Activation Index score
|
During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum
|
|
Patient-reported outcome: Pregnancy experiences
Time Frame: 3rd trimester, delivery hospitalization
|
nuMoM2b Pregnancy Experience Scale-Brief score
|
3rd trimester, delivery hospitalization
|
|
Patient-reported outcome: Satisfaction with care (antenatal and postpartum)
Time Frame: During pregnancy, delivery hospitalization, and 6-12 weeks postpartum
|
Prenatal Care Satisfaction Scale score and modified scale for postpartum care satisfaction
|
During pregnancy, delivery hospitalization, and 6-12 weeks postpartum
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant experiences with patient navigation and antenatal care process mapping
Time Frame: Enrollment through delivery hospitalization, an average of 28 weeks
|
Participants randomized to receive navigation will complete in-depth qualitative interviews on their experiences with the navigation program.
Interviews will address satisfaction with social and medical care received, engagement with the program, antenatal care experience, relationship with the navigator, experience with PATH navigation, and areas for improvement.
Interviews will also include process mapping to understand antenatal care processes and PATH's contributions to their optimization
|
Enrollment through delivery hospitalization, an average of 28 weeks
|
|
Satisfaction with navigation (interpersonal aspects)
Time Frame: During pregnancy and through 9 months postpartum
|
Survey - Patient Satisfaction with Interpersonal Relationship with Navigator Scale (among participants receiving navigation)
|
During pregnancy and through 9 months postpartum
|
|
Satisfaction with navigation (logistical aspects)
Time Frame: During pregnancy and through 9 months postpartum
|
Survey - Patient Satisfaction with Logistical Aspects with Navigator Scale (among participants receiving navigation)
|
During pregnancy and through 9 months postpartum
|
|
Clinician, navigator, and administrator interviews and process mapping
Time Frame: Through completion of study, an average of 5 years
|
Clinicians, navigators, and administrators will complete in-depth interviews and process mapping exercises.
Interviews will solicit their input whether PATH is successful, preferred patient navigation elements, and how they perceive PATH to affect patient care.
Interviews will also include implementation science-guided process mapping exercises to understand how PATH navigation intersects with system-level healthcare, patient-level needs, and organizational processes.
|
Through completion of study, an average of 5 years
|
|
Navigation intensity and activities
Time Frame: Through completion of study, an average of 5 years
|
Mixed methods data on navigation intensity (number of interactions over the duration of intervention performance), types of activities completed for/with participants, types of communication modes used, and types of health care team interactions.
Data will be integrated from navigator logs of navigation activities and quarterly in-depth qualitative interviews with the navigators.
|
Through completion of study, an average of 5 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Lynn M Yee, MD, MPH, Northwestern University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00218597
- R01MD020130 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.